Neximmune Property Plant And Equipment Gross vs Total Current Liabilities Analysis
NEXI Stock | USD 3.13 0.03 0.95% |
Neximmune financial indicator trend analysis is infinitely more than just investigating Neximmune recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neximmune is a good investment. Please check the relationship between Neximmune Property Plant And Equipment Gross and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.
Property Plant And Equipment Gross vs Total Current Liabilities
Property Plant And Equipment Gross vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neximmune Property Plant And Equipment Gross account and Total Current Liabilities. At this time, the significance of the direction appears to have weak relationship.
The correlation between Neximmune's Property Plant And Equipment Gross and Total Current Liabilities is 0.33. Overlapping area represents the amount of variation of Property Plant And Equipment Gross that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Neximmune, assuming nothing else is changed. The correlation between historical values of Neximmune's Property Plant And Equipment Gross and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Gross of Neximmune are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Property Plant And Equipment Gross i.e., Neximmune's Property Plant And Equipment Gross and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.33 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Property Plant And Equipment Gross
Total Current Liabilities
Total Current Liabilities is an item on Neximmune balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Neximmune are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Neximmune's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neximmune current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.As of now, Neximmune's Selling General Administrative is increasing as compared to previous years. The Neximmune's current Enterprise Value Over EBITDA is estimated to increase to 0.03, while Issuance Of Capital Stock is projected to decrease to 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 861.4K | 576.7K | 1.0M | 702.8K | Interest Income | 52.5K | 664.4K | 973.3K | 1.0M |
Neximmune fundamental ratios Correlations
Click cells to compare fundamentals
Neximmune Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neximmune fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 13.7M | 11.3M | 91.0M | 43.1M | 8.6M | 8.2M | |
Other Current Liab | 1.9M | 2.5M | 6.2M | 7.4M | 3.7B | 3.9B | |
Total Current Liabilities | 3.0M | 27.0M | 7.2M | 10.3M | 5.1M | 4.8M | |
Total Stockholder Equity | 10.6M | (15.8M) | 83.8M | 32.3M | 3.5M | 3.3M | |
Net Tangible Assets | (43.0M) | (69.4M) | 83.8M | 32.3M | 37.1M | 39.0M | |
Property Plant And Equipment Net | 2.6M | 2.9M | 4.4M | 5.4M | 1.4M | 1.3M | |
Net Debt | 44.5M | 14.1M | (30.3M) | (33.6M) | (3.1M) | (3.0M) | |
Retained Earnings | (47.7M) | (77.6M) | (127.7M) | (190.2M) | (222.6M) | (211.5M) | |
Accounts Payable | 1.2M | 2.8M | 1.0M | 2.4M | 1.3M | 1.8M | |
Cash | 9.1M | 5.0M | 30.3M | 34.6M | 3.2M | 3.0M | |
Non Current Assets Total | 2.7M | 2.9M | 4.8M | 5.7M | 3.2M | 3.9M | |
Non Currrent Assets Other | 103.6K | 23.4K | 324.1K | 265.0K | 1.8M | 1.9M | |
Cash And Short Term Investments | 10.1M | 5.0M | 81.8M | 34.6M | 4.6M | 4.4M | |
Common Stock Shares Outstanding | 900.9K | 910.3K | 913.2K | 962.4K | 1.0M | 1.9M | |
Liabilities And Stockholders Equity | 13.7M | 11.3M | 91.0M | 43.1M | 8.6M | 8.2M | |
Other Current Assets | 833.2K | 78.5K | 99.2K | 2.7M | 215.2K | 204.5K | |
Other Stockholder Equity | 4.7M | 8.2M | (90.8B) | 222.5M | 226.1M | 237.4M | |
Total Liab | 3.1M | 27.1M | 7.3M | 10.8M | 5.1M | 4.8M | |
Net Invested Capital | (43.0M) | (50.3M) | 83.8M | 32.3M | 3.5M | 3.7M | |
Property Plant And Equipment Gross | 2.6M | 2.9M | 6.7M | 5.4M | 3.0M | 4.1M | |
Total Current Assets | 11.0M | 8.4M | 86.3M | 37.4M | 5.4M | 5.1M | |
Net Working Capital | 8.0M | (18.6M) | 79.1M | 27.0M | 316.7K | 300.9K | |
Property Plant Equipment | 2.6M | 2.9M | 4.4M | 5.4M | 6.2M | 3.7M |
Currently Active Assets on Macroaxis
MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce | |
MSFT | Microsoft | |
GOOG | Alphabet Inc Class C |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Neximmune Stock analysis
When running Neximmune's price analysis, check to measure Neximmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neximmune is operating at the current time. Most of Neximmune's value examination focuses on studying past and present price action to predict the probability of Neximmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neximmune's price. Additionally, you may evaluate how the addition of Neximmune to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Neximmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neximmune. If investors know Neximmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neximmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (30.82) | Return On Assets (0.71) | Return On Equity (1.81) |
The market value of Neximmune is measured differently than its book value, which is the value of Neximmune that is recorded on the company's balance sheet. Investors also form their own opinion of Neximmune's value that differs from its market value or its book value, called intrinsic value, which is Neximmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neximmune's market value can be influenced by many factors that don't directly affect Neximmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neximmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neximmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neximmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.